Saturday, November 21, 2015 4:03:42 PM
I see AXON market cap getting a haircut after the lockup period expiration.
I see AVXL getting Wirehouse coverage under one of following situations. 1. Accumulation by a Wirehouse and/or a major institutions being advised by the a Wirehouse. Then when they are finished and want to distribute some back to retail they come out with buy rating. 2. Market cap of AVXL reaches 1 billion therefore rating coverage. 3. Most likely and soonest would be a secondary offering underwritten by a Wirehouse. Who of course would rate AVXL a buy.
A secondary would mostly be priced at 50d MA when current price exceeds 50d MA by an amount that would be great enough to be an incentive to those purchaser's of the secondary shares.
What usually happens to the price of the stock when secondary is announced? It could fall below the secondary offer price. Then recover to at or above in a matter of a week or two. Which give confident and informed retail investors a chance to make additions at below the price paid buy those institutions purchasing the secondary shares and then have those purchased shares quickly inflate in price as shock subsides and investors realize that a secondary offering is validation and confirmation of the value of the company especially when the offering is fully exercised in the initial amount and the amount is conditional excess shares to meet the demand. Therefore a well received and executed secondary offering while being a minor dilution would be very positive in perception of the company as well as best way to raise capital other than a partnership.
So do not be afraid of the big wave or steep mountain just know what usually happens in those situations so one can surf it or ski it.
Two antidotial cases in point. TNXP and ANTH. Tonix&Anthera both clinical stage small cap biotechnology companies. Both recently in last six months and fairly close in time did secondaries priced both at exactly $7.50. I was long both and watched Level 2 all day everyday babysitting them. They both behaved as a stated above and both recovered. I was able to accumulate more below the secondary offer price. Both were doing OK afterwards and rose above the secondary price within a few weeks. Of course not long after that Martin S crashed the sector with his price gouging as Mrs. CLINTON ceased on it.
But these are just antidotes not a statistic on how stocks behave during and after a secondary offering.
I want to see all the longs here WIN.
The keys to WINNING are confidence and preparation. Those of us that have done DD are confident. Let us prepare each other for the games yet to come. We know and should hope that at some point there will be a secondary offering of common stock.
Is anyone has statistics or studies in how stocks especially biotechnology cos. behave during a secondary offering please share it with us now. The secondary should not happen until the stock near $8 handle or more but it could be in the works presently.
Please share your thoughts. Everyone on this important subject that has not been explored enough here.
I do not post often but I read every post everyday and I do appreciate in imput from everyone here.
God Bless you all and your families. Happy Thanksgiving.
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM